Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE
“Closer to the personalization of renal transplant treatment.
First study to evaluate the functionality of the IMMUNOBIOGRAM® to predict the immunosuppressive response.”